Announcements Trials
Browse Landscape

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Glucose Metabolism Disorders 1Glucose Intolerance 1Fatty Liver 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Proton Magnetic Resonance Spectroscopy × Clear all
NCT03204461 2017-07-02

Glucose Metabolism in Different PCOS Phenotypes

Medical University of Vienna

Completed
73 enrolled

Fatty Liver, Polycystic Ovary Syndrome, Glucose Intolerance, Glucose Metabolism Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡